Shanghai Haoyuan Chemexpress Co (SHSE:688131) Buyback Yield % : 0.00 (As of Mar. 22, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Shanghai Haoyuan Chemexpress Co's current buyback yield was 0.00%.

Shanghai Haoyuan Chemexpress Co Buyback Yield % Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Buyback Yield % Chart

Shanghai Haoyuan Chemexpress Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buyback Yield %

Get a 7-Day Free Trial

Shanghai Haoyuan Chemexpress Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Haoyuan Chemexpress Co's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Buyback Yield % falls into.

Shanghai Haoyuan Chemexpress Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Shanghai Haoyuan Chemexpress Co's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	7829.154596988
	=	0.00%

Shanghai Haoyuan Chemexpress Co's annualized Buyback Yield for the quarter that ended in Sep. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	7072.44937
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Shanghai Haoyuan Chemexpress Co Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haoyuan Chemexpress Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Buyback Yield %

Traded in Other Exchanges

N/A

Address

No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.chemexpress.com.cn

Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.

Executives

Mei Kui

Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines